Accessibility Statement Skip Navigation
  • Resources
  • Blog
  • Journalists
  • Webcasts
  • Data Privacy
  • Français
  • my CNW 
    • Login
    • Register
  • Client Login 
    • Online Member Centre
    • Next Gen Communications Cloud
    • Cision Communications Cloud®
  • Sign Up
  • Send a Release
Return to PR Newswire homepage
  • News
  • Products
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
Advanced Search
  • News in Focus
      • Browse News Releases

      • All News Releases
      • All Public Company
      • News Releases Overview

      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
      • Multimedia Gallery Overview

      • Trending Topics

      • All Trending Topics
  • Business
      • Auto & Transportation

      • All Automotive & Transportation
      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • Auto & Transportation Overview

      • View All Auto & Transportation

      • Business Technology

      • All Business Technology
      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • Business Technology Overview

      • View All Business Technology

      • Entertain­ment & Media

      • All Entertain­ment & Media
      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • Entertain­ment & Media Overview

      • View All Entertain­ment & Media

      • Financial Services & Investing

      • All Financial Services & Investing
      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • Financial Services & Investing Overview

      • View All Financial Services & Investing

      • General Business

      • All General Business
      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • General Business Overview

      • View All General Business

  • Science & Tech
      • Consumer Technology

      • All Consumer Technology
      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • Consumer Technology Overview

      • View All Consumer Technology

      • Energy & Natural Resources

      • All Energy
      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • Energy & Natural Resources Overview

      • View All Energy & Natural Resources

      • Environ­ment

      • All Environ­ment
      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • Environ­ment Overview

      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • All Heavy Industry & Manufacturing
      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • Heavy Industry & Manufacturing Overview

      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • All Telecomm­unications
      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • Telecomm­unications Overview

      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • All Consumer Products & Retail
      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • Consumer Products & Retail Overview

      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • All Entertain­ment & Media
      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • Entertain­ment & Media Overview

      • View All Entertain­ment & Media

      • Health

      • All Health
      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • Health Overview

      • View All Health

      • Sports

      • All Sports
      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • Sports Overview

      • View All Sports

      • Travel

      • All Travel
      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • Travel Overview

      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • All Policy & Public Interest
      • Advocacy Group Opinion
      • Animal Welfare
      • Canadian Federal Government
      • Canadian Municipal Government
      • Canadian Provincial Government
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • Policy & Public Interest Overview

      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • All People & Culture
      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • People & Culture Overview

      • View All People & Culture

  • Advanced Search
  • Overview
  • Multichannel Amplification
  • Monitoring
  • Distribution
  • Multimedia
  • Guaranteed Paid Placement
  • AI Tools
  • IR
  • Become a Client
  • Request a Demo
  • Editorial Bureaus
  • Partnerships
  • General Enquiries
  • Media
  • Worldwide Offices
  • Hamburger menu
  • Cision Canada
  • Send a Release
  • FR
    • Phone

    • 877-269-7890 from 8 AM - 10 PM ET

    • ALL CONTACT INFO
    • Contact Cision

      877-269-7890
      from 8 AM - 10 PM ET

  • Send a Release
  • Sign Up
  • Resources
  • Blog
  • Journalists
  • Webcasts
  • GDPR
  • News in Focus
    • Browse All News
    • Multimedia Gallery
    • Trending Topics
  • Business
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
    • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Sign Up
  • Resources
  • Blog
  • Journalists
  • Webcasts
  • GDPR
  • Overview
  • Multichannel Amplification
  • Monitoring
  • Distribution
  • Multimedia
  • Guaranteed Paid Placement
  • AI Tools
  • IR
  • Send a Release
  • Sign Up
  • Resources
  • Blog
  • Journalists
  • Webcasts
  • GDPR
  • Become a Client
  • Request a Demo
  • Editorial Bureaus
  • Partnerships
  • General Enquiries
  • Media
  • Worldwide Offices
  • Send a Release
  • Sign Up
  • Resources
  • Blog
  • Journalists
  • Webcasts
  • GDPR

New pan-Canadian Terry Fox Research Institute network receives close to $4-million to find better tools to treat prostate cancer Français


News provided by

Terry Fox Research Institute

Jul 25, 2012, 10:00 ET

Share this article

Share toX

Share this article

Share toX

What forms of prostate cancer require immediate treatment and which don't?

MONTREAL, July 25, 2012 /CNW Telbec/ - Prostate cancer is the most commonly diagnosed cancer and the third-leading cause of cancer-related death in Canadian men. Screening has enabled earlier diagnosis of prostate cancer, but with three out of four men actually diagnosed with a non-lethal form, should they all undergo the same treatment? A new pan-Canadian network of prostate cancer researchers formed by the Terry Fox Research Institute aims to address this need with approximately $4-million provided by the Terry Fox Foundation and the Canadian Partnership Against Cancer. The funding was announced today at the CHUM Research Centre (CRCHUM).

TFRI's Canadian Prostate Cancer Biomarker Network (CPCBN) brings together top scientists and clinicians at leading prostate cancer care and research centres in Quebec, Ontario and British Columbia to take aim at answering this question with the goal of providing better tools - including new and more effective biomarkers -- to treat and manage the disease. Over the next four years, the group will work to identify new ways to determine what forms of prostate cancer require immediate treatment and which don't, as well as how to better predict which patients, following treatment (surgery or radiation therapy), are at risk of their cancer progressing.

Total funding for the network is $3,995,326, with the Partnership having provided $550,000.

"We are extremely pleased to create this important biomarker research network and to provide a total of $3.5 million to address an important clinical question that both doctors who treat the disease and men who are diagnosed with it must consider," said Mr. Darrell Fox, senior advisor for the Terry Fox Research Institute (TFRI). "Having more tools at their disposal for decision making will help clinicians  to better determine what treatment is best for a patient's particular prostate cancer."

"Bringing together expertise and resources from across the country through this network will help to advance the science needed to improve the lives of Canadian men diagnosed with prostate cancer," says Dr. Robin Harkness, research specialist with the Canadian Partnership Against Cancer, a national organization funded by Health Canada to lead the implementation of a co-ordinated cancer strategy, and executive director of the Canadian Cancer Research Alliance. "This is one of several projects the Partnership has launched with the Terry Fox Research Institute with the practical goal of identifying emerging technologies that can improve the early detection and treatment of cancer and lead to better outcomes."

"This new collaborative team has leadership and a track record across the research and clinical spectrums in understanding and treating prostate cancer and, collectively, they have excellent access to tissue samples and serum that are important to conducting studies to find new and effective biomarkers in this area. We appreciate the support of both the Terry Fox Foundation and the Canadian Partnership Against Cancer in funding this impressive network and the important work they are undertaking to improve care for patients," said Dr. Victor Ling, TFRI President and Scientific Director.

Dr. Fred Saad, professor and chief of urology at the CHUM and director of prostate cancer research at the Montreal Cancer Institute-CRCHUM, leads the study. "We're excited about the opportunity to work together to identify significant biomarker combinations to be used with existing clinical tools to allow clinicians to better assess the risk of tumour progression of early-stage tumours before and after treatment. If this study goes as we hope it will, its impact will be profound -- reducing recurrence and improving quality of life for men who have the disease - as well as bringing economic and societal benefits through the more efficient and effective use of health resources," says Dr. Saad.

He and project colleagues at CRCHUM will work with investigators at several partner institutions: McGill University, McGill University Health Centre (MUHC), the Research Institute of the MUHC , the Université Laval, the Centre hospitalier universitaire de Québec (CHUQ) in Quebec;  Kingston General Hospital (Queen's University), Sunnybrook Health Sciences Centre, and the University Health Network (UHN) - Princess Margaret Hospital in Ontario; and the University of British Columbia, the Vancouver Prostate Centre and the Vancouver Coastal Health Research Institute in BC. The knowledge transfer will be performed in collaboration with experts from the three provinces as well as from Manitoba.

The investigators will contribute to the studies in various ways, including providing clinical samples and data from patients having undergone surgery and radiotherapy, and also patients who have been put on active surveillance. This network will also be combining research expertise in biomarker and genetic profiling of cancers that will greatly increase the speed at which results will be obtained.

The project will run until March 2016. The network has developed a knowledge translation component  to reach out to interested partners and to engage the medical community in the implementation of their findings and including a biomarker-driven approach for diagnosing and managing the disease as an element in clinical decision making. These include: The Canadian Urology Association, NCIC Clinical Trials Group, The Canada Urologic Oncology Group, and Prostate Cancer Canada.

About The Terry Fox Research Institute

Launched in October 2007, The Terry Fox Research Institute (TFRI) is the brainchild of The Terry Fox Foundation (TFF). TFF maintains the vision and principles of Terry Fox while raising money for cancer research through the annual Terry Fox Run, National School Run Day and other fundraising initiatives which, to date, have raised over $600 million worldwide. TFRI seeks to improve significantly the outcomes of cancer research for the patient through a highly collaborative, team-oriented, milestone-based approach to research that will enable discoveries to translate quickly into practical solutions for cancer patients worldwide. TFRI collaborates with over 50 cancer hospitals and research organizations across Canada. TFRI headquarters are in Vancouver, BC. www.tfri.ca.

About the CHUM

The Centre hospitalier de l'Université de Montréal (CHUM) is the largest francophone teaching hospital in North America. Known for excellent care and the expertise of its specialists, every year it welcomes more than half a million patients not only from the greater Montreal region but also the entire province of Quebec. The essence of its mission is the application of innovative approaches to healthcare, the search for new knowledge, the promotion of health and the transfer of knowledge. Boasting a rich history, the CHUM is looking to the future with the ongoing construction of new facilities and its research centre in downtown Montreal, a comprehensive project on a single site valued at nearly $2.5 billion. The CHUM Research Centre will open its doors in 2013. It will be followed in 2016 by the unveiling of the new CHUM, a world-class teaching hospital in tune with its community where it plays a major role, in a socially aware perspective of sustainable development and concerted urban approach. It is also an active member of the Réseau universitaire intégré de santé (RUIS) de l'Université de Montréal. chumontreal.com

SOURCE: Terry Fox Research Institute

Kelly Curwin
Director, Communications and Public Affairs
Office: 604-675-8223
Cell: 778-237-8158
[email protected] 

Sylvie Robitaille 
Communication Advisor 
Centre hospitalier de l'Université de Montréal (CHUM)
Telephone: (514) 890-8000, extension 15262
Pager: (514) 801-1101 

Modal title

Organization Profile

Terry Fox Research Institute

    Also from this source

  • New Terry Fox research program developed BY cancer patients FOR cancer patients - the first in Canada - supports 10 teams addressing gaps and disparities in care, access, treatment

Related Organization(s)

Centre hospitalier de l'Université de Montréal

Contact Cision

  • 866-245-2317
    from 8 AM - 10 PM ET
  • Become a Client
  • Request a Demo
  • Editorial Bureaus
  • Partnerships
  • General Enquiries
  • Media

Products

  • Cision Communications Cloud®
  • Media Monitoring
  • Content Distribution
  • Multimedia Distribution
  • Measurement & Analytics
  • Investor Relations

About

  • About Cision Canada
  • About Cision
  • Media Partners
  • Careers
  • Accessibility Statement
  • APAC
  • APAC - Simplified Chinese
  • APAC - Traditional Chinese
  • Brazil
  • Canada
  • Czech
  • Denmark
  • Finland
  • France
  • Germany
  • India
  • Indonesia
  • Israel
  • Japan
  • Korea
  • Mexico
  • Middle East
  • Middle East - Arabic
  • Netherlands
  • Norway
  • Poland
  • Portugal
  • Russia
  • Slovakia
  • Spain
  • Sweden
  • United States
  • Vietnam

My Services

  • All News Releases
  • Online Member Centre
  • Next Gen Communications Cloud
  • Cision Communications Cloud®
  • my CNW

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact Cision

Products

About

My Services
  • All News Releases
  • Online Member Centre
  • Next Gen Communications Cloud
  • Cision Communications Cloud
  • my CNW
877-269-7890
from 8 AM - 10 PM ET
  • Terms of Use
  • Information Security Policy
  • Site Map
  • Cookie Settings
  • Accessibility Statement
Copyright © 2025 CNW Group Ltd. All Rights Reserved. A Cision company.